Growth oriented Ampersand focuses on growth-oriented investments in healthcare and life sciences, indicating potential value in scalable services, advanced manufacturing, and CDMO partnerships that align with their portfolio companies.

Global expansion With offices in Boston, Amsterdam, and London and recent expansion to London, there are opportunities to engage cross-border capabilities, regulatory expertise, and international supply chain solutions for portfolio companies expanding to Europe.

Operational edge Ampersand emphasizes operating experience alongside investment, suggesting receptiveness to consulting, value-building services, and performance improvement offerings that can accelerate portfolio growth.

Healthcare specialization A dedicated healthcare and life sciences focus, including recent acquisitions in packaging, development and manufacturing, indicates demand for specialized vendors in regulatory, clinical, and manufacturing scale-up services.

Mid-market focus Targeting revenues typically between 10 and 200 million and investments of 10 to 200 million signals openness to mid-market suppliers, contract manufacturers, packaging, and specialty technology providers.